Skip to content
Politically.com Search all
Menu

Kentucky 2026RS

HB 512

AN ACT relating to prescription drugs.

Source: Open States / PluralUpdated 2026-11-11 12:11:04 UTC.

Official record

Measure details

Jurisdiction
Kentucky
Session
2026RS
Chamber
lower
Classification
bill
Subjects
Actuarial Analysis, Drugs And Medicines, Education, Higher, Effective Dates, Delayed, Health Benefit Plan Mandate, Insurance, Health, Local Mandate, Pharmacists, State Agencies, State Employee Health Plan Mandate, State Employees
Introduced / first action
2026-01-28 05:00:00

Source-supplied abstracts

Amend KRS 304.17A-164 to define and redefine terms; establish cost-sharing requirements for prescription drugs; require rebates to be passed through; establish confidentiality requirements for the rebate information; create a new section of KRS 365.880 to 365.900 to provide that the actual amount of rebates received is a trade secret; provide that compliance with prescription drug cost-sharing and rebate requirements shall not be in violation of the Uniform Trade Secrets Act; amend KRS 304.17C-125, 304.38A-115, 18A.225, and 164.2871 to apply the cost-sharing and rebate requirements for prescription drugs to limited health service benefit plans, limited health service organizations, the state employee health plan, and self-insured employer group health plans provided by the governing board of a state postsecondary education institution; apply provisions to health plans issued or renewed on or after January 1, 2027; EFFECTIVE January 1, 2027.

Sponsors

Source-supplied history

Actions

  1. to Banking & Insurance (H)

    referral-committee
  2. to Committee on Committees (H)

    referral-committee
  3. introduced in House

    introduction

Recorded votes

Roll calls

No recorded vote is supplied for this bill.

When supplied by the API

Related measures

No resolvable related measure is supplied.